Condition
Sentinel Lymph Node Biopsy (SLNB) clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Sentinel Lymph Node Biopsy (SLNB) clinical trials that are recruiting, at sites in 8 countries (most in Netherlands (2), Italy (2), Tunisia (1)). By phase: Phase 2 (1). The most active sponsors are St. Antonius Hospital (2), European Institute of Oncology (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 8Countries
Newest Sentinel Lymph Node Biopsy (SLNB) clinical trials
All recruiting trials (9)
-
Using Patent Blue to map sentinel lymph nodes in early ovarian cancer
This study will try injecting Patent Blue dye into the ovarian ligaments during surgery for people with early-stage ovarian cancer to find the first draining lymph nodes and see if that can stage disease accurately while avoiding full lymph node removal.
-
Using indocyanine green to find sentinel lymph nodes during mastectomy
This pilot will test whether injecting indocyanine green and using fluorescence during mastectomy can find sentinel lymph nodes in women with clinically node-negative invasive breast cancer.
-
Targeted removal of a marked lymph node for early hormone-receptor positive breast cancer with limited node spread
This trial tests whether removing the pre-marked suspicious lymph node along with the sentinel lymph node during initial surgery lets people with early ER+/PR+ HER2‑ breast cancer and 1–2 suspicious nodes avoid a full axillary lymph node dissection.
-
Fast detection of cancer in sentinel lymph nodes using a new NIR-II fluorescent probe.
This test applies a new near-infrared (NIR-II) fluorescent probe to freshly removed sentinel lymph nodes to quickly tell adults with breast cancer whether the cancer has spread there.
-
Using indocyanine green to identify sentinel lymph nodes during breast cancer surgery
This project tests whether indocyanine green dye and a fluorescence camera can be used instead of the radioactive tracer to find sentinel lymph nodes in adults having breast cancer surgery who are clinically node-negative.
-
Targeted sentinel node biopsy for breast cancer patients with limited axillary nodal disease
This audit will test if removing the marked node along with the sentinel nodes can identify people with only 1–2 positive axillary nodes so some can avoid a full axillary dissection, for adults with cT1-2 breast cancer and biopsy-proven axillary metastases with no more than two abnormal nodes on imaging.
-
Sentinel lymph node biopsy after neoadjuvant chemotherapy for inflammatory breast cancer
This trial will test whether sentinel lymph node biopsy after preoperative chemotherapy is feasible and safe for people with inflammatory breast cancer who initially had extensive lymph node involvement.
-
Using photo-medicine to guide reoperation for lymph nodes in recurrent breast cancer
This study is testing a new method using light to help doctors find lymph nodes during surgery for women with recurrent breast cancer to see if it improves treatment planning.
-
Comparing two surgical approaches for early mouth cancers
This study is testing whether a less invasive surgery for early mouth cancers can provide similar survival rates while being easier on patients and more affordable than the standard approach.
Related topics
Quick answers
How many Sentinel Lymph Node Biopsy (SLNB) clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in Netherlands (2 trials), Italy (2 trials), Tunisia (1 trial), China (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.